Re: Re:
Well sorry but this is the very crux of the matter here leaving aside all the other stuff.
Your idea that LeMond would just stop EPO in 91 becaue it was illegal makes very little sense. As I posted before, 1992 was further into the EPO era than say 89 for example but he still had a better pre-Tour build up than any of the previous years. In summary your theory would be LeMond was on EPO in 89/90 but sucked right up to just before the Tour. He stopped EPO in 91 but was still capable of finishing Top 10 in the Tour including 2nd by 8 seconds to Miguel Indurain in the first TT. That would also totally blow your notion that he was blood doping previously out of the water if he could finish that high without EPO or blood doping against riders who were on EPO.
So to continue your hypothesis, in 1992 he has a good Tour build-up, 9th at Paris-Roubaix, 1st at Tour du Pont, 11th at Dauphine, 4th at Switzerland all without EPO but then somehow finishes outside the Time-cut at the Tour because he isn't on EPO. How do you go from finishing 7th in the Tour in 91 without EPO to missing the cut in 92 or from 4th in Suisse in mid June to elimination in July. Sorry, but there was not that much of a sea change in that space of time. In general most of the stories and retrospectives would suggest 93/94 as the major sea change re EPO.
The alternative theories are he was on EPO during all that period but his health problems leading to sudden loss of form could negate any benefits he might have gained from EPO as in spring 89 or Tour 92 or even Tour 91. Thus leading us back to the original story that LeMonds huge swings in from where primarily down to health reasons. When he was healthy, he was capble of competing close to his pre-shooting level but when not, he was nowhere.
It is perfecty understandable why people would see LeMonds huge swing in form as evidence of EPO usage at that time, especially in 89 and thus why the rumours from the PDM guys might have started. LeMond has a huge swing in form, EPO is entering the peloton at that time, it has been produced in the US, LeMond is from the US, PDM are pissed at LeMond from 88 and do the usual clinic thing of joining the dots and come up with the LeMond/EPO story. None of this makes the rumour true but it is now out there just like the Floyd blood dumping example. Pie in the sky rumours were not uncommon and I have seen this first hand and can give an example if you wish.
Bus as I stated previously, performances over the subsequent years would suggest health problems were the root of the swings in forms rather than EPO usage but hey I am sure the EPO angle was a lot more salicious and reaffirming for his rivals.
Maxiton said:pmcg76 said:Maxiton said:But I didn't say anything about EPO in 1986. I specifically said, way up thread and now, blood doping in 86. By which I mean autologous transfusion. EPO was in clinical trials in 86, but I'm assuming a bike racer wouldn't have had access to it. If EPO was used, 1989 is far more likely.
EPO might have compensated for whatever he lost by being shot, if he was the only one on it. By 1991, though, the jig was up in that others were on it, too. And if I'm not mistaken, EPO was proscribed by the UCI after May of '91. So, if you were a rider who lived by the principle of staying within the rules, EPO would have thereafter been off limits, meaning that LeMond could have used it at the Tour in 89 and 90, but not 91.
To me the time-lines make little sense. Like I posted before, in spring of that year 89 LeMond was competing with the likes of Fignon, Roche, Indurain, Mottet, Madiot at Criterium International in March. A week later, he was finishing miles down at Flanders despite have performed at Flanders previously. At the Giro he was finishing behind Paul Kimmage in mountains stages. That makes little sense. Was he on EPO for March and then stopped for the major classics? Why would he stop? Why would he not use EPO in prep for the Giro which was one of his targets for the season? Why only start using EPO halfway through the Giro?
Also in 89/90/91 LeMond rode the same prep DuPont/Giro/Suisse and then the Tour. In each of those seasons his form peaked for the Tour after riding poorly in the preceeding races. After his failure at the Tour in 91, he changed his programme to DuPont/Dauphine/Suisse in 92. He showed much better form like 9th in Paris-Roubaix, won Du Pont, 11th at the Dauphine and 4th at Suisse, then flopped at the Tour finishing outside the time-limit in the mountains. How does a rider go from 4th in Suisse to outside the time limit at the Tour a few weeks later if they are on EPO. Again, that makes zero sense.
The timelines just seem way off for EPO usage.
Good points. I don't know, off hand. Maybe he was trying as much as possible to rely on his undeniable gifts, only to find them lacking due to the gunshot, and later due to the use by his competitors of EPO after it was banned? Maybe someone else has some ideas?
Well sorry but this is the very crux of the matter here leaving aside all the other stuff.
Your idea that LeMond would just stop EPO in 91 becaue it was illegal makes very little sense. As I posted before, 1992 was further into the EPO era than say 89 for example but he still had a better pre-Tour build up than any of the previous years. In summary your theory would be LeMond was on EPO in 89/90 but sucked right up to just before the Tour. He stopped EPO in 91 but was still capable of finishing Top 10 in the Tour including 2nd by 8 seconds to Miguel Indurain in the first TT. That would also totally blow your notion that he was blood doping previously out of the water if he could finish that high without EPO or blood doping against riders who were on EPO.
So to continue your hypothesis, in 1992 he has a good Tour build-up, 9th at Paris-Roubaix, 1st at Tour du Pont, 11th at Dauphine, 4th at Switzerland all without EPO but then somehow finishes outside the Time-cut at the Tour because he isn't on EPO. How do you go from finishing 7th in the Tour in 91 without EPO to missing the cut in 92 or from 4th in Suisse in mid June to elimination in July. Sorry, but there was not that much of a sea change in that space of time. In general most of the stories and retrospectives would suggest 93/94 as the major sea change re EPO.
The alternative theories are he was on EPO during all that period but his health problems leading to sudden loss of form could negate any benefits he might have gained from EPO as in spring 89 or Tour 92 or even Tour 91. Thus leading us back to the original story that LeMonds huge swings in from where primarily down to health reasons. When he was healthy, he was capble of competing close to his pre-shooting level but when not, he was nowhere.
It is perfecty understandable why people would see LeMonds huge swing in form as evidence of EPO usage at that time, especially in 89 and thus why the rumours from the PDM guys might have started. LeMond has a huge swing in form, EPO is entering the peloton at that time, it has been produced in the US, LeMond is from the US, PDM are pissed at LeMond from 88 and do the usual clinic thing of joining the dots and come up with the LeMond/EPO story. None of this makes the rumour true but it is now out there just like the Floyd blood dumping example. Pie in the sky rumours were not uncommon and I have seen this first hand and can give an example if you wish.
Bus as I stated previously, performances over the subsequent years would suggest health problems were the root of the swings in forms rather than EPO usage but hey I am sure the EPO angle was a lot more salicious and reaffirming for his rivals.
